Aspire Pharma Ltd in the news
Developing innovative pharmaceuticals
Tamtam found 13 recent articles about Aspire Pharma Ltd.
- The building of Aspire Pharma and values
This specialty generics pharmaceutical company focuses on enhancing existing medicines and scaling its global reach following its 2021 acquisition by H.I.G. Capital.
- Aspire Pharma acquires Charlwood Pharma, looks for international expansion
Aspire Pharma has acquired Charlwood Pharma to secure its niche generic medicine pipeline and accelerate international expansion.
- Behind every prescription is a person: reframing medicines optimisation for patient-centric impact in the NHS
This report advocates for a shift in the NHS from viewing medicines as a controllable cost to treating them as strategic assets that drive patient-centric outcomes and system efficiency.
- Aspire acquires UK distribution rights from Tetris
Aspire Pharma acquired UK distribution rights for antibiotic and cardiovascular treatments from Tetris Pharma to expand its specialty generic portfolio.
- Katharina Pink
Aspire Pharma appointed Katharina Pink as Chief Commercial Officer and Managing Director of its German operations to drive international expansion.
- Women in the pharmaceutical industry
Aspire Pharma highlights the strategic importance of gender diversity and its internal progress in increasing female representation across management roles.
- Cetraxal® preparations – change to special container status from sub-pack to complete pack
Aspire Pharma's Cetraxal ear drops will transition to complete pack special container status in the UK Drug Tariff from April 2025.
- Reimagining medicines optimisation: A call to action for reducing health inequalities
Strategic reform in NHS medicines optimisation is needed to shift focus from cost-cutting to patient-centric outcomes and resilient supply chains.
- Aspire completes acquisition of Cenoté Pharma Ltd
Aspire Pharma Ltd acquired Cenoté Pharma Ltd to expand into metabolic disorder treatments and strengthen its European market presence.
- Dr Andriy Krendyukov
Aspire Pharma appointed Dr Andriy Krendyukov as Chief Medical Officer and Jonathan Chambers as Senior Vice President – Scientific Affairs to bolster its medical and scientific leadership.
- Aspire Pharma Continues LCCC’s Medical Centre Sponsorship
Aspire Pharma Ltd has become the new sponsor of Leicestershire County Cricket Club's medical centre, continuing the partnership after acquiring the previous sponsor, Morningside Pharmaceuticals.
- Morningside Pharmaceuticals sold to Aspire Pharma
Aspire Pharma acquired Morningside Pharmaceuticals to expand its market position and integrate over 120 mid and late-stage medicine programs.
- Acquisition deal sees pharma firms join forces
Aspire Pharma acquired Morningside Pharmaceuticals to create one of the UK's largest pharmaceutical entities and expand its international product portfolio.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Aspire Pharma Ltd?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies